Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - SYNERGY PHARMACEUTICALS, INC. | sgyp-ex321x93018x10q.htm |
| EX-31.2 - EXHIBIT 31.2 - SYNERGY PHARMACEUTICALS, INC. | sgyp-ex312x93018x10q.htm |
| EX-31.1 - EXHIBIT 31.1 - SYNERGY PHARMACEUTICALS, INC. | sgyp-ex311x93018x10q.htm |
| EX-10.3 - EXHIBIT 10.3 - SYNERGY PHARMACEUTICALS, INC. | synergy-luoxinagreemen.htm |
| EX-10.2 - EXHIBIT 10.2 - SYNERGY PHARMACEUTICALS, INC. | a12454925v6tax-synergy.htm |
| EX-10.1 - EXHIBIT 10.1 - SYNERGY PHARMACEUTICALS, INC. | separationagreementmar.htm |
| 10-Q - 10-Q - SYNERGY PHARMACEUTICALS, INC. | sgyp-20180930.htm |
EXHIBIT 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
SYNERGY PHARMACEUTICALS INC.
FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2018
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I am the Executive Vice President, Chief Financial Officer of Synergy Pharmaceuticals Inc., a Delaware corporation (the “Company”). I am delivering this certificate in connection with the Form 10-Q of the Company for the quarter ended September 30, 2018 and filed with the Securities and Exchange Commission (“Form 10-Q”).
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I hereby certify that, to the best of my knowledge, the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: | November 9, 2018 | /s/ GARY G. GEMIGNANI | |||||||||
Gary G. Gemignani | |||||||||||
Executive Vice President, Chief Financial Officer | |||||||||||